These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7334137)

  • 1. Salivary elimination of cyclophosphamide in man.
    Ritschel WA; Bykadi G; Norman EJ; Cluxton RJ; Denton D
    J Clin Pharmacol; 1981; 21(11):461-5. PubMed ID: 7334137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of salivary elimination of cyclophosphamide in man.
    Juma FD; Rogers HJ; Trounce JR
    Br J Clin Pharmacol; 1979 Nov; 8(5):455-8. PubMed ID: 508550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary and plasma pharmacokinetics of topotecan in patients with metastatic epithelial ovarian cancer.
    Boucaud M; Pinguet F; Poujol S; Romieu G; Cupissol D; Astre C; Culine S; Bressolle F
    Eur J Cancer; 2001 Dec; 37(18):2357-64. PubMed ID: 11720828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazepam and N-desmethyldiazepam in saliva of hospital inpatients.
    Giles HG; Miller R; Macleod SM; Sellers EM
    J Clin Pharmacol; 1980; 20(2-3):71-6. PubMed ID: 6769976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific salivary excretion of tocainide enantiomers in man.
    Pillai GK; Axelson JE; Kerr CR; McErlane KM
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):209-21. PubMed ID: 6424192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and salivary pharmacokinetics of caffeine in man.
    Newton R; Broughton LJ; Lind MJ; Morrison PJ; Rogers HJ; Bradbrook ID
    Eur J Clin Pharmacol; 1981; 21(1):45-52. PubMed ID: 7333346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring prednisolone and prednisone in saliva: a population pharmacokinetic approach in healthy volunteers.
    Teeninga N; Guan Z; Freijer J; Ruiter AF; Ackermans MT; Kist-van Holthe JE; van Gelder T; Nauta J
    Ther Drug Monit; 2013 Aug; 35(4):485-92. PubMed ID: 23783167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological monitoring of diazinon exposure using saliva in an animal model.
    Lu C; Irish RM; Fenske R
    J Toxicol Environ Health A; 2003 Dec; 66(24):2315-25. PubMed ID: 14630523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetic analysis of theophylline in serum and saliva.
    Trnavská Z; Rejholec V; Elis J; Spicák V
    Int J Clin Pharmacol Res; 1987; 7(5):329-35. PubMed ID: 3667005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correspondence of salivary and plasma concentrations of atrazine in rats under variable salivary flow rate and plasma concentration.
    Lu C; Anderson LC; Morgan MS; Fenske RA
    J Toxicol Environ Health; 1997 Nov; 52(4):317-29. PubMed ID: 9354177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
    BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion of proguanil in human saliva.
    Onyeji CO; Ogunbona FA; Dixon PA
    J Pharm Pharmacol; 1989 Dec; 41(12):872-3. PubMed ID: 2576454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva secretion of chloroquine in man.
    Ogubona FA; Lawal AA; Onyeji CO
    J Pharm Pharmacol; 1986 Jul; 38(7):535-7. PubMed ID: 2875158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of lamotrigine (Lamictal) in plasma and saliva.
    Trnavska Z; Krejcova H; Tkaczykovam ; Salcmanova Z; Elis J
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():211-5. PubMed ID: 1820881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulation and evaluation of nicotine intake during passive smoking: cotinine measurements in body fluids of nonsmokers given intravenous infusions of nicotine.
    Curvall M; Vala EK; Enzell CR; Wahren J
    Clin Pharmacol Ther; 1990 Jan; 47(1):42-9. PubMed ID: 2295218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers.
    Curvall M; Elwin CE; Kazemi-Vala E; Warholm C; Enzell CR
    Eur J Clin Pharmacol; 1990; 38(3):281-7. PubMed ID: 2340848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of free and N4-acetylated sulfapyridine concentrations in the plasma and saliva of man after sulfasalazine (salicylazosulfapyridine) administration: preliminary findings.
    Bates TR; Blumenthal HP; Pieniaszek HJ
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):183-9. PubMed ID: 9675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disopyramide concentrations in saliva.
    Aitio ML; Virtanen R; Lammintausta R
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.